nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—lung cancer—mediastinal cancer	0.789	1	CtDrD
Crizotinib—PRKD1—IGF1 pathway—PTPN1—mediastinal cancer	0.00453	0.0548	CbGpPWpGaD
Crizotinib—FER—N-cadherin signaling events—PTPN1—mediastinal cancer	0.00391	0.0474	CbGpPWpGaD
Crizotinib—MET—Signaling events mediated by TCPTP—PTPN1—mediastinal cancer	0.00312	0.0378	CbGpPWpGaD
Crizotinib—IGF1R—IGF1 pathway—PTPN1—mediastinal cancer	0.0031	0.0376	CbGpPWpGaD
Crizotinib—FER—Signaling events mediated by PTP1B—PTPN1—mediastinal cancer	0.00292	0.0353	CbGpPWpGaD
Crizotinib—MET—Posttranslational regulation of adherens junction stability and dissassembly—PTPN1—mediastinal cancer	0.0027	0.0326	CbGpPWpGaD
Crizotinib—CSF1R—Signaling events mediated by TCPTP—PTPN1—mediastinal cancer	0.0022	0.0266	CbGpPWpGaD
Crizotinib—IGF1R—Posttranslational regulation of adherens junction stability and dissassembly—PTPN1—mediastinal cancer	0.00213	0.0258	CbGpPWpGaD
Crizotinib—JAK2—Regulation of IFNG signaling—PTPN1—mediastinal cancer	0.00199	0.0241	CbGpPWpGaD
Crizotinib—RPS6KB1—IGF1 pathway—PTPN1—mediastinal cancer	0.00183	0.0221	CbGpPWpGaD
Crizotinib—MET—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—PTPN1—mediastinal cancer	0.00179	0.0217	CbGpPWpGaD
Crizotinib—JAK3—Signaling events mediated by TCPTP—PTPN1—mediastinal cancer	0.00178	0.0216	CbGpPWpGaD
Crizotinib—CSF1R—Signaling events mediated by PTP1B—PTPN1—mediastinal cancer	0.00178	0.0216	CbGpPWpGaD
Crizotinib—PTK2—Integrin alphaIIb beta3 signaling—PTPN1—mediastinal cancer	0.00171	0.0207	CbGpPWpGaD
Crizotinib—TYK2—Regulation of IFNA signaling—PTPN1—mediastinal cancer	0.0016	0.0193	CbGpPWpGaD
Crizotinib—PTK2—IGF1 pathway—PTPN1—mediastinal cancer	0.00157	0.019	CbGpPWpGaD
Crizotinib—MAP4K2—Insulin Signaling—PTPN1—mediastinal cancer	0.00142	0.0171	CbGpPWpGaD
Crizotinib—LYN—Growth hormone receptor signaling—PTPN1—mediastinal cancer	0.00138	0.0167	CbGpPWpGaD
Crizotinib—MAP4K5—Insulin Signaling—PTPN1—mediastinal cancer	0.00136	0.0164	CbGpPWpGaD
Crizotinib—PTK2—Platelet Aggregation (Plug Formation)—PTPN1—mediastinal cancer	0.00133	0.0161	CbGpPWpGaD
Crizotinib—RPS6KB1—Insulin Pathway—PTPN1—mediastinal cancer	0.00132	0.016	CbGpPWpGaD
Crizotinib—JAK2—Growth hormone receptor signaling—PTPN1—mediastinal cancer	0.00129	0.0156	CbGpPWpGaD
Crizotinib—MAP3K12—Insulin Signaling—PTPN1—mediastinal cancer	0.00126	0.0153	CbGpPWpGaD
Crizotinib—BLK—Signaling events mediated by PTP1B—PTPN1—mediastinal cancer	0.00124	0.015	CbGpPWpGaD
Crizotinib—FGR—Signaling events mediated by PTP1B—PTPN1—mediastinal cancer	0.00124	0.0149	CbGpPWpGaD
Crizotinib—YES1—Signaling events mediated by PTP1B—PTPN1—mediastinal cancer	0.000997	0.0121	CbGpPWpGaD
Crizotinib—TYK2—Signaling events mediated by PTP1B—PTPN1—mediastinal cancer	0.000918	0.0111	CbGpPWpGaD
Crizotinib—SRC—Integrin alphaIIb beta3 signaling—PTPN1—mediastinal cancer	0.000911	0.011	CbGpPWpGaD
Crizotinib—RPS6KB1—Leptin signaling pathway—PTPN1—mediastinal cancer	0.000879	0.0106	CbGpPWpGaD
Crizotinib—IGF1R—Insulin Signaling—PTPN1—mediastinal cancer	0.000814	0.00985	CbGpPWpGaD
Crizotinib—MAPK7—Insulin Signaling—PTPN1—mediastinal cancer	0.000796	0.00964	CbGpPWpGaD
Crizotinib—ABL1—Posttranslational regulation of adherens junction stability and dissassembly—PTPN1—mediastinal cancer	0.000789	0.00955	CbGpPWpGaD
Crizotinib—TYK2—Interferon alpha/beta signaling—PTPN1—mediastinal cancer	0.000768	0.00929	CbGpPWpGaD
Crizotinib—PTK2—Leptin signaling pathway—PTPN1—mediastinal cancer	0.000754	0.00913	CbGpPWpGaD
Crizotinib—LYN—Signaling events mediated by PTP1B—PTPN1—mediastinal cancer	0.000743	0.009	CbGpPWpGaD
Crizotinib—MAP3K2—Insulin Signaling—PTPN1—mediastinal cancer	0.000725	0.00878	CbGpPWpGaD
Crizotinib—MAP4K1—Insulin Signaling—PTPN1—mediastinal cancer	0.000725	0.00878	CbGpPWpGaD
Crizotinib—PTK2—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—PTPN1—mediastinal cancer	0.000716	0.00867	CbGpPWpGaD
Crizotinib—SRC—Platelet Aggregation (Plug Formation)—PTPN1—mediastinal cancer	0.000708	0.00857	CbGpPWpGaD
Crizotinib—JAK2—Signaling events mediated by PTP1B—PTPN1—mediastinal cancer	0.000696	0.00842	CbGpPWpGaD
Crizotinib—SRC—Signaling events mediated by TCPTP—PTPN1—mediastinal cancer	0.000665	0.00805	CbGpPWpGaD
Crizotinib—MERTK—Hemostasis—PTPN1—mediastinal cancer	0.000663	0.00803	CbGpPWpGaD
Crizotinib—MAP3K3—Insulin Signaling—PTPN1—mediastinal cancer	0.000624	0.00755	CbGpPWpGaD
Crizotinib—BLK—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.000614	0.00744	CbGpPWpGaD
Crizotinib—FGR—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.000612	0.00741	CbGpPWpGaD
Crizotinib—LCK—Signaling events mediated by PTP1B—PTPN1—mediastinal cancer	0.000609	0.00738	CbGpPWpGaD
Crizotinib—SRC—Posttranslational regulation of adherens junction stability and dissassembly—PTPN1—mediastinal cancer	0.000575	0.00696	CbGpPWpGaD
Crizotinib—JAK2—Interferon gamma signaling—PTPN1—mediastinal cancer	0.000555	0.00672	CbGpPWpGaD
Crizotinib—SRC—Signaling events mediated by PTP1B—PTPN1—mediastinal cancer	0.000539	0.00653	CbGpPWpGaD
Crizotinib—JAK2—Leptin signaling pathway—PTPN1—mediastinal cancer	0.000519	0.00628	CbGpPWpGaD
Crizotinib—YES1—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.000494	0.00598	CbGpPWpGaD
Crizotinib—RPS6KB1—Insulin Signaling—PTPN1—mediastinal cancer	0.000479	0.0058	CbGpPWpGaD
Crizotinib—JAK3—Platelet activation, signaling and aggregation—PTPN1—mediastinal cancer	0.000454	0.0055	CbGpPWpGaD
Crizotinib—SRC—Leptin signaling pathway—PTPN1—mediastinal cancer	0.000402	0.00487	CbGpPWpGaD
Crizotinib—MAP3K3—Cytokine Signaling in Immune system—PTPN1—mediastinal cancer	0.000399	0.00482	CbGpPWpGaD
Crizotinib—SRC—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—PTPN1—mediastinal cancer	0.000382	0.00463	CbGpPWpGaD
Crizotinib—JAK3—Cytokine Signaling in Immune system—PTPN1—mediastinal cancer	0.000376	0.00455	CbGpPWpGaD
Crizotinib—LYN—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.000369	0.00446	CbGpPWpGaD
Crizotinib—ABL1—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.000367	0.00444	CbGpPWpGaD
Crizotinib—TYK2—Interferon Signaling—PTPN1—mediastinal cancer	0.000358	0.00433	CbGpPWpGaD
Crizotinib—JAK2—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.000345	0.00417	CbGpPWpGaD
Crizotinib—RIPK2—Cytokine Signaling in Immune system—PTPN1—mediastinal cancer	0.000335	0.00406	CbGpPWpGaD
Crizotinib—PTK2B—Cytokine Signaling in Immune system—PTPN1—mediastinal cancer	0.00033	0.004	CbGpPWpGaD
Crizotinib—PTK2—Platelet activation, signaling and aggregation—PTPN1—mediastinal cancer	0.000318	0.00385	CbGpPWpGaD
Crizotinib—JAK2—bronchus—mediastinal cancer	0.000312	0.00244	CbGeAlD
Crizotinib—TESK1—thyroid gland—mediastinal cancer	0.000311	0.00243	CbGeAlD
Crizotinib—TEK—Hemostasis—PTPN1—mediastinal cancer	0.000311	0.00376	CbGpPWpGaD
Crizotinib—TBK1—trachea—mediastinal cancer	0.00031	0.00243	CbGeAlD
Crizotinib—PTK2—trachea—mediastinal cancer	0.00031	0.00243	CbGeAlD
Crizotinib—LIMK1—lymph node—mediastinal cancer	0.00031	0.00243	CbGeAlD
Crizotinib—TNK1—lung—mediastinal cancer	0.00031	0.00242	CbGeAlD
Crizotinib—YES1—hematopoietic system—mediastinal cancer	0.000309	0.00242	CbGeAlD
Crizotinib—EPHA2—bronchus—mediastinal cancer	0.000309	0.00241	CbGeAlD
Crizotinib—TYK2—trachea—mediastinal cancer	0.000308	0.00241	CbGeAlD
Crizotinib—BMPR1B—lung—mediastinal cancer	0.000306	0.0024	CbGeAlD
Crizotinib—MAP3K19—lung—mediastinal cancer	0.000306	0.0024	CbGeAlD
Crizotinib—MAP4K1—lung—mediastinal cancer	0.000306	0.0024	CbGeAlD
Crizotinib—STK10—hematopoietic system—mediastinal cancer	0.000306	0.00239	CbGeAlD
Crizotinib—TAOK3—hematopoietic system—mediastinal cancer	0.000305	0.00238	CbGeAlD
Crizotinib—EPHA4—cardiac atrium—mediastinal cancer	0.000304	0.00237	CbGeAlD
Crizotinib—MERTK—bone marrow—mediastinal cancer	0.000303	0.00237	CbGeAlD
Crizotinib—MERTK—thyroid gland—mediastinal cancer	0.000303	0.00237	CbGeAlD
Crizotinib—PRKD3—lymph node—mediastinal cancer	0.000302	0.00236	CbGeAlD
Crizotinib—LCK—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.000302	0.00366	CbGpPWpGaD
Crizotinib—MAP3K3—bronchus—mediastinal cancer	0.000301	0.00235	CbGeAlD
Crizotinib—TEK—bronchus—mediastinal cancer	0.000301	0.00235	CbGeAlD
Crizotinib—MAP4K5—bronchus—mediastinal cancer	0.000301	0.00235	CbGeAlD
Crizotinib—TNK2—lung—mediastinal cancer	0.0003	0.00235	CbGeAlD
Crizotinib—IGF1R—lung—mediastinal cancer	0.0003	0.00235	CbGeAlD
Crizotinib—RPS6KB1—trachea—mediastinal cancer	0.000299	0.00234	CbGeAlD
Crizotinib—SRC—hematopoietic system—mediastinal cancer	0.000297	0.00232	CbGeAlD
Crizotinib—LCK—trachea—mediastinal cancer	0.000297	0.00232	CbGeAlD
Crizotinib—MAP4K2—lung—mediastinal cancer	0.000296	0.00232	CbGeAlD
Crizotinib—LIMK2—thyroid gland—mediastinal cancer	0.000296	0.00231	CbGeAlD
Crizotinib—NUAK2—bone marrow—mediastinal cancer	0.000296	0.00231	CbGeAlD
Crizotinib—AXL—trachea—mediastinal cancer	0.000296	0.00231	CbGeAlD
Crizotinib—DSTYK—lymph node—mediastinal cancer	0.000295	0.00231	CbGeAlD
Crizotinib—NUAK2—thyroid gland—mediastinal cancer	0.000295	0.00231	CbGeAlD
Crizotinib—PTK2B—lymphoid tissue—mediastinal cancer	0.000294	0.0023	CbGeAlD
Crizotinib—ACVR1—bone marrow—mediastinal cancer	0.000294	0.0023	CbGeAlD
Crizotinib—FLT3—bone marrow—mediastinal cancer	0.000294	0.0023	CbGeAlD
Crizotinib—ACVR1—thyroid gland—mediastinal cancer	0.000293	0.00229	CbGeAlD
Crizotinib—MAP3K12—thyroid gland—mediastinal cancer	0.000293	0.00229	CbGeAlD
Crizotinib—STK3—lung—mediastinal cancer	0.000292	0.00229	CbGeAlD
Crizotinib—TIE1—lung—mediastinal cancer	0.000292	0.00229	CbGeAlD
Crizotinib—BLK—lymph node—mediastinal cancer	0.000292	0.00228	CbGeAlD
Crizotinib—TBK1—cardiac atrium—mediastinal cancer	0.000292	0.00228	CbGeAlD
Crizotinib—TYK2—cardiac atrium—mediastinal cancer	0.00029	0.00227	CbGeAlD
Crizotinib—LTK—lymph node—mediastinal cancer	0.000288	0.00226	CbGeAlD
Crizotinib—CASK—lymph node—mediastinal cancer	0.000288	0.00226	CbGeAlD
Crizotinib—EPHB6—bronchus—mediastinal cancer	0.000288	0.00225	CbGeAlD
Crizotinib—STK35—thyroid gland—mediastinal cancer	0.000287	0.00224	CbGeAlD
Crizotinib—AURKA—lung—mediastinal cancer	0.000285	0.00223	CbGeAlD
Crizotinib—SLK—trachea—mediastinal cancer	0.000285	0.00223	CbGeAlD
Crizotinib—TESK1—lung—mediastinal cancer	0.000282	0.00221	CbGeAlD
Crizotinib—EPHB4—trachea—mediastinal cancer	0.000282	0.00221	CbGeAlD
Crizotinib—RPS6KB1—cardiac atrium—mediastinal cancer	0.00028	0.00219	CbGeAlD
Crizotinib—JAK2—trachea—mediastinal cancer	0.00028	0.00219	CbGeAlD
Crizotinib—ABL2—thyroid gland—mediastinal cancer	0.00028	0.00219	CbGeAlD
Crizotinib—MAPK7—lymph node—mediastinal cancer	0.000279	0.00218	CbGeAlD
Crizotinib—TXK—lymph node—mediastinal cancer	0.000279	0.00218	CbGeAlD
Crizotinib—YES1—bronchus—mediastinal cancer	0.000278	0.00217	CbGeAlD
Crizotinib—AXL—cardiac atrium—mediastinal cancer	0.000278	0.00217	CbGeAlD
Crizotinib—EPHA2—trachea—mediastinal cancer	0.000277	0.00217	CbGeAlD
Crizotinib—BMP2K—bone marrow—mediastinal cancer	0.000277	0.00216	CbGeAlD
Crizotinib—FES—lymph node—mediastinal cancer	0.000277	0.00216	CbGeAlD
Crizotinib—BMP2K—thyroid gland—mediastinal cancer	0.000276	0.00216	CbGeAlD
Crizotinib—MAP3K2—lymphoid tissue—mediastinal cancer	0.000276	0.00216	CbGeAlD
Crizotinib—STK10—bronchus—mediastinal cancer	0.000276	0.00216	CbGeAlD
Crizotinib—MERTK—lung—mediastinal cancer	0.000275	0.00215	CbGeAlD
Crizotinib—TAOK3—bronchus—mediastinal cancer	0.000274	0.00215	CbGeAlD
Crizotinib—JAK2—Interferon Signaling—PTPN1—mediastinal cancer	0.000271	0.00328	CbGpPWpGaD
Crizotinib—MAP3K3—trachea—mediastinal cancer	0.00027	0.00211	CbGeAlD
Crizotinib—MAP4K5—trachea—mediastinal cancer	0.00027	0.00211	CbGeAlD
Crizotinib—PTK2—lymphoid tissue—mediastinal cancer	0.00027	0.00211	CbGeAlD
Crizotinib—TBK1—lymphoid tissue—mediastinal cancer	0.00027	0.00211	CbGeAlD
Crizotinib—LIMK2—lung—mediastinal cancer	0.000269	0.0021	CbGeAlD
Crizotinib—TYK2—lymphoid tissue—mediastinal cancer	0.000269	0.0021	CbGeAlD
Crizotinib—NUAK2—lung—mediastinal cancer	0.000268	0.00209	CbGeAlD
Crizotinib—SRC—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.000267	0.00324	CbGpPWpGaD
Crizotinib—PTK2B—bone marrow—mediastinal cancer	0.000267	0.00209	CbGeAlD
Crizotinib—SLK—cardiac atrium—mediastinal cancer	0.000267	0.00209	CbGeAlD
Crizotinib—CSF1R—hematopoietic system—mediastinal cancer	0.000267	0.00209	CbGeAlD
Crizotinib—PTK2B—thyroid gland—mediastinal cancer	0.000267	0.00209	CbGeAlD
Crizotinib—MAP3K12—lung—mediastinal cancer	0.000266	0.00208	CbGeAlD
Crizotinib—ACVR1—lung—mediastinal cancer	0.000266	0.00208	CbGeAlD
Crizotinib—FLT3—lung—mediastinal cancer	0.000266	0.00208	CbGeAlD
Crizotinib—EPHB4—cardiac atrium—mediastinal cancer	0.000265	0.00208	CbGeAlD
Crizotinib—RIPK2—bone marrow—mediastinal cancer	0.000265	0.00207	CbGeAlD
Crizotinib—RIPK2—thyroid gland—mediastinal cancer	0.000264	0.00207	CbGeAlD
Crizotinib—JAK2—cardiac atrium—mediastinal cancer	0.000263	0.00206	CbGeAlD
Crizotinib—MET—lymph node—mediastinal cancer	0.000261	0.00205	CbGeAlD
Crizotinib—STK35—lung—mediastinal cancer	0.000261	0.00204	CbGeAlD
Crizotinib—EPHA2—cardiac atrium—mediastinal cancer	0.00026	0.00204	CbGeAlD
Crizotinib—RPS6KB1—lymphoid tissue—mediastinal cancer	0.00026	0.00203	CbGeAlD
Crizotinib—YES1—Cytokine Signaling in Immune system—PTPN1—mediastinal cancer	0.000259	0.00314	CbGpPWpGaD
Crizotinib—FGR—lymphoid tissue—mediastinal cancer	0.000258	0.00202	CbGeAlD
Crizotinib—EPHB6—trachea—mediastinal cancer	0.000258	0.00202	CbGeAlD
Crizotinib—AXL—lymphoid tissue—mediastinal cancer	0.000257	0.00201	CbGeAlD
Crizotinib—EPHA4—thyroid gland—mediastinal cancer	0.000256	0.002	CbGeAlD
Crizotinib—MAP3K3—cardiac atrium—mediastinal cancer	0.000254	0.00199	CbGeAlD
Crizotinib—MAP4K5—cardiac atrium—mediastinal cancer	0.000254	0.00199	CbGeAlD
Crizotinib—TEK—cardiac atrium—mediastinal cancer	0.000254	0.00199	CbGeAlD
Crizotinib—ABL2—lung—mediastinal cancer	0.000254	0.00199	CbGeAlD
Crizotinib—CDK7—lymph node—mediastinal cancer	0.000253	0.00198	CbGeAlD
Crizotinib—MAP3K2—bone marrow—mediastinal cancer	0.000251	0.00197	CbGeAlD
Crizotinib—TAOK2—lymph node—mediastinal cancer	0.000251	0.00196	CbGeAlD
Crizotinib—BMP2K—lung—mediastinal cancer	0.000251	0.00196	CbGeAlD
Crizotinib—MAP3K2—thyroid gland—mediastinal cancer	0.000251	0.00196	CbGeAlD
Crizotinib—YES1—trachea—mediastinal cancer	0.00025	0.00195	CbGeAlD
Crizotinib—TAOK3—trachea—mediastinal cancer	0.000246	0.00193	CbGeAlD
Crizotinib—TBK1—bone marrow—mediastinal cancer	0.000246	0.00193	CbGeAlD
Crizotinib—IRAK1—Cytokine Signaling in Immune system—PTPN1—mediastinal cancer	0.000246	0.00298	CbGpPWpGaD
Crizotinib—TBK1—thyroid gland—mediastinal cancer	0.000246	0.00192	CbGeAlD
Crizotinib—PTK2—thyroid gland—mediastinal cancer	0.000246	0.00192	CbGeAlD
Crizotinib—TYK2—bone marrow—mediastinal cancer	0.000244	0.00191	CbGeAlD
Crizotinib—JAK2—lymphoid tissue—mediastinal cancer	0.000244	0.00191	CbGeAlD
Crizotinib—TYK2—thyroid gland—mediastinal cancer	0.000244	0.00191	CbGeAlD
Crizotinib—EPHB6—cardiac atrium—mediastinal cancer	0.000243	0.0019	CbGeAlD
Crizotinib—PTK2B—lung—mediastinal cancer	0.000242	0.00189	CbGeAlD
Crizotinib—EPHA3—lymph node—mediastinal cancer	0.000242	0.00189	CbGeAlD
Crizotinib—ACVR1B—lymph node—mediastinal cancer	0.000242	0.00189	CbGeAlD
Crizotinib—EPHA2—lymphoid tissue—mediastinal cancer	0.000241	0.00189	CbGeAlD
Crizotinib—IRAK1—bone marrow—mediastinal cancer	0.000241	0.00189	CbGeAlD
Crizotinib—TXK—Immune System—PTPN1—mediastinal cancer	0.000241	0.00292	CbGpPWpGaD
Crizotinib—IRAK1—thyroid gland—mediastinal cancer	0.000241	0.00188	CbGeAlD
Crizotinib—RIPK2—lung—mediastinal cancer	0.00024	0.00188	CbGeAlD
Crizotinib—CSF1R—bronchus—mediastinal cancer	0.00024	0.00188	CbGeAlD
Crizotinib—TYK2—Cytokine Signaling in Immune system—PTPN1—mediastinal cancer	0.000239	0.00289	CbGpPWpGaD
Crizotinib—RPS6KB1—bone marrow—mediastinal cancer	0.000237	0.00185	CbGeAlD
Crizotinib—RPS6KB1—thyroid gland—mediastinal cancer	0.000236	0.00185	CbGeAlD
Crizotinib—MAP4K5—lymphoid tissue—mediastinal cancer	0.000235	0.00184	CbGeAlD
Crizotinib—TEK—lymphoid tissue—mediastinal cancer	0.000235	0.00184	CbGeAlD
Crizotinib—LCK—bone marrow—mediastinal cancer	0.000235	0.00184	CbGeAlD
Crizotinib—FGR—bone marrow—mediastinal cancer	0.000235	0.00184	CbGeAlD
Crizotinib—LCK—thyroid gland—mediastinal cancer	0.000235	0.00184	CbGeAlD
Crizotinib—FGR—thyroid gland—mediastinal cancer	0.000235	0.00184	CbGeAlD
Crizotinib—YES1—cardiac atrium—mediastinal cancer	0.000235	0.00183	CbGeAlD
Crizotinib—JAK3—Hemostasis—PTPN1—mediastinal cancer	0.000234	0.00283	CbGpPWpGaD
Crizotinib—AXL—thyroid gland—mediastinal cancer	0.000234	0.00183	CbGeAlD
Crizotinib—LYN—Platelet activation, signaling and aggregation—PTPN1—mediastinal cancer	0.000234	0.00283	CbGpPWpGaD
Crizotinib—EPHA4—lung—mediastinal cancer	0.000232	0.00182	CbGeAlD
Crizotinib—TAOK3—cardiac atrium—mediastinal cancer	0.000232	0.00181	CbGeAlD
Crizotinib—JAK3—lymph node—mediastinal cancer	0.000231	0.0018	CbGeAlD
Crizotinib—DCLK1—lymph node—mediastinal cancer	0.000229	0.00179	CbGeAlD
Crizotinib—MAP3K2—lung—mediastinal cancer	0.000228	0.00178	CbGeAlD
Crizotinib—PLK4—lymph node—mediastinal cancer	0.000228	0.00178	CbGeAlD
Crizotinib—STK4—lymph node—mediastinal cancer	0.000226	0.00177	CbGeAlD
Crizotinib—SLK—bone marrow—mediastinal cancer	0.000226	0.00176	CbGeAlD
Crizotinib—SRC—cardiac atrium—mediastinal cancer	0.000226	0.00176	CbGeAlD
Crizotinib—SLK—thyroid gland—mediastinal cancer	0.000225	0.00176	CbGeAlD
Crizotinib—STK4—Signaling Pathways—PTPN1—mediastinal cancer	0.000225	0.00272	CbGpPWpGaD
Crizotinib—EPHB4—bone marrow—mediastinal cancer	0.000224	0.00175	CbGeAlD
Crizotinib—EPHB4—thyroid gland—mediastinal cancer	0.000223	0.00175	CbGeAlD
Crizotinib—TBK1—lung—mediastinal cancer	0.000223	0.00174	CbGeAlD
Crizotinib—PTK2—lung—mediastinal cancer	0.000223	0.00174	CbGeAlD
Crizotinib—JAK2—bone marrow—mediastinal cancer	0.000222	0.00174	CbGeAlD
Crizotinib—JAK2—thyroid gland—mediastinal cancer	0.000222	0.00174	CbGeAlD
Crizotinib—TYK2—lung—mediastinal cancer	0.000222	0.00173	CbGeAlD
Crizotinib—EPHA2—thyroid gland—mediastinal cancer	0.000219	0.00171	CbGeAlD
Crizotinib—JAK2—Platelet activation, signaling and aggregation—PTPN1—mediastinal cancer	0.000219	0.00265	CbGpPWpGaD
Crizotinib—IRAK1—lung—mediastinal cancer	0.000219	0.00171	CbGeAlD
Crizotinib—YES1—lymphoid tissue—mediastinal cancer	0.000217	0.0017	CbGeAlD
Crizotinib—CSF1R—trachea—mediastinal cancer	0.000216	0.00169	CbGeAlD
Crizotinib—STK10—lymphoid tissue—mediastinal cancer	0.000215	0.00169	CbGeAlD
Crizotinib—TAOK3—lymphoid tissue—mediastinal cancer	0.000215	0.00168	CbGeAlD
Crizotinib—RPS6KB1—lung—mediastinal cancer	0.000215	0.00168	CbGeAlD
Crizotinib—MAP3K3—bone marrow—mediastinal cancer	0.000214	0.00168	CbGeAlD
Crizotinib—MAP4K5—bone marrow—mediastinal cancer	0.000214	0.00168	CbGeAlD
Crizotinib—ALK—lymph node—mediastinal cancer	0.000214	0.00167	CbGeAlD
Crizotinib—FER—lymph node—mediastinal cancer	0.000214	0.00167	CbGeAlD
Crizotinib—MAP3K3—thyroid gland—mediastinal cancer	0.000214	0.00167	CbGeAlD
Crizotinib—MAP4K5—thyroid gland—mediastinal cancer	0.000214	0.00167	CbGeAlD
Crizotinib—TEK—thyroid gland—mediastinal cancer	0.000214	0.00167	CbGeAlD
Crizotinib—LCK—lung—mediastinal cancer	0.000213	0.00167	CbGeAlD
Crizotinib—FGR—lung—mediastinal cancer	0.000213	0.00167	CbGeAlD
Crizotinib—AXL—lung—mediastinal cancer	0.000212	0.00166	CbGeAlD
Crizotinib—TNK1—lymph node—mediastinal cancer	0.000212	0.00166	CbGeAlD
Crizotinib—ABL1—hematopoietic system—mediastinal cancer	0.000211	0.00165	CbGeAlD
Crizotinib—MAP4K1—lymph node—mediastinal cancer	0.00021	0.00164	CbGeAlD
Crizotinib—BMPR1B—lymph node—mediastinal cancer	0.00021	0.00164	CbGeAlD
Crizotinib—SRC—lymphoid tissue—mediastinal cancer	0.000209	0.00164	CbGeAlD
Crizotinib—TNK2—lymph node—mediastinal cancer	0.000205	0.00161	CbGeAlD
Crizotinib—IGF1R—lymph node—mediastinal cancer	0.000205	0.00161	CbGeAlD
Crizotinib—SLK—lung—mediastinal cancer	0.000204	0.0016	CbGeAlD
Crizotinib—EPHB6—thyroid gland—mediastinal cancer	0.000204	0.0016	CbGeAlD
Crizotinib—EPHB4—lung—mediastinal cancer	0.000203	0.00159	CbGeAlD
Crizotinib—MAP4K2—lymph node—mediastinal cancer	0.000203	0.00158	CbGeAlD
Crizotinib—CSF1R—cardiac atrium—mediastinal cancer	0.000203	0.00158	CbGeAlD
Crizotinib—JAK2—lung—mediastinal cancer	0.000202	0.00158	CbGeAlD
Crizotinib—FGR—Hemostasis—PTPN1—mediastinal cancer	0.0002	0.00242	CbGpPWpGaD
Crizotinib—STK3—lymph node—mediastinal cancer	0.0002	0.00156	CbGeAlD
Crizotinib—TIE1—lymph node—mediastinal cancer	0.0002	0.00156	CbGeAlD
Crizotinib—EPHA2—lung—mediastinal cancer	0.000199	0.00156	CbGeAlD
Crizotinib—YES1—bone marrow—mediastinal cancer	0.000198	0.00155	CbGeAlD
Crizotinib—YES1—thyroid gland—mediastinal cancer	0.000198	0.00154	CbGeAlD
Crizotinib—STK10—bone marrow—mediastinal cancer	0.000196	0.00153	CbGeAlD
Crizotinib—STK10—thyroid gland—mediastinal cancer	0.000196	0.00153	CbGeAlD
Crizotinib—TAOK3—bone marrow—mediastinal cancer	0.000195	0.00153	CbGeAlD
Crizotinib—TAOK3—thyroid gland—mediastinal cancer	0.000195	0.00152	CbGeAlD
Crizotinib—AURKA—lymph node—mediastinal cancer	0.000195	0.00152	CbGeAlD
Crizotinib—TEK—lung—mediastinal cancer	0.000194	0.00152	CbGeAlD
Crizotinib—MAP4K5—lung—mediastinal cancer	0.000194	0.00152	CbGeAlD
Crizotinib—MAP3K3—lung—mediastinal cancer	0.000194	0.00152	CbGeAlD
Crizotinib—LYN—Cytokine Signaling in Immune system—PTPN1—mediastinal cancer	0.000193	0.00234	CbGpPWpGaD
Crizotinib—TESK1—lymph node—mediastinal cancer	0.000193	0.00151	CbGeAlD
Crizotinib—LCK—Platelet activation, signaling and aggregation—PTPN1—mediastinal cancer	0.000192	0.00232	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—PTPN1—mediastinal cancer	0.000191	0.00231	CbGpPWpGaD
Crizotinib—SRC—thyroid gland—mediastinal cancer	0.00019	0.00149	CbGeAlD
Crizotinib—ABL1—bronchus—mediastinal cancer	0.00019	0.00148	CbGeAlD
Crizotinib—MERTK—lymph node—mediastinal cancer	0.000188	0.00147	CbGeAlD
Crizotinib—CSF1R—lymphoid tissue—mediastinal cancer	0.000188	0.00147	CbGeAlD
Crizotinib—EPHB6—lung—mediastinal cancer	0.000186	0.00145	CbGeAlD
Crizotinib—LIMK2—lymph node—mediastinal cancer	0.000184	0.00144	CbGeAlD
Crizotinib—NUAK2—lymph node—mediastinal cancer	0.000183	0.00143	CbGeAlD
Crizotinib—IKBKE—Immune System—PTPN1—mediastinal cancer	0.000183	0.00221	CbGpPWpGaD
Crizotinib—FLT3—lymph node—mediastinal cancer	0.000182	0.00142	CbGeAlD
Crizotinib—ACVR1—lymph node—mediastinal cancer	0.000182	0.00142	CbGeAlD
Crizotinib—MAP3K12—lymph node—mediastinal cancer	0.000182	0.00142	CbGeAlD
Crizotinib—JAK2—Cytokine Signaling in Immune system—PTPN1—mediastinal cancer	0.000181	0.00219	CbGpPWpGaD
Crizotinib—YES1—lung—mediastinal cancer	0.000179	0.0014	CbGeAlD
Crizotinib—STK35—lymph node—mediastinal cancer	0.000178	0.00139	CbGeAlD
Crizotinib—STK10—lung—mediastinal cancer	0.000178	0.00139	CbGeAlD
Crizotinib—TAOK3—lung—mediastinal cancer	0.000177	0.00139	CbGeAlD
Crizotinib—ABL2—lymph node—mediastinal cancer	0.000174	0.00136	CbGeAlD
Crizotinib—SRC—lung—mediastinal cancer	0.000173	0.00135	CbGeAlD
Crizotinib—BMP2K—lymph node—mediastinal cancer	0.000172	0.00134	CbGeAlD
Crizotinib—CSF1R—bone marrow—mediastinal cancer	0.000171	0.00134	CbGeAlD
Crizotinib—CSF1R—thyroid gland—mediastinal cancer	0.000171	0.00133	CbGeAlD
Crizotinib—ABL1—trachea—mediastinal cancer	0.00017	0.00133	CbGeAlD
Crizotinib—SRC—Platelet activation, signaling and aggregation—PTPN1—mediastinal cancer	0.00017	0.00205	CbGpPWpGaD
Crizotinib—MAPK7—Immune System—PTPN1—mediastinal cancer	0.000166	0.00201	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—PTPN1—mediastinal cancer	0.000166	0.00201	CbGpPWpGaD
Crizotinib—PTK2B—lymph node—mediastinal cancer	0.000166	0.0013	CbGeAlD
Crizotinib—RIPK2—lymph node—mediastinal cancer	0.000164	0.00128	CbGeAlD
Crizotinib—PTK2—Hemostasis—PTPN1—mediastinal cancer	0.000164	0.00198	CbGpPWpGaD
Crizotinib—YES1—Hemostasis—PTPN1—mediastinal cancer	0.000162	0.00195	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—PTPN1—mediastinal cancer	0.00016	0.00194	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—PTPN1—mediastinal cancer	0.00016	0.00194	CbGpPWpGaD
Crizotinib—ABL1—cardiac atrium—mediastinal cancer	0.00016	0.00125	CbGeAlD
Crizotinib—EPHA4—lymph node—mediastinal cancer	0.000159	0.00124	CbGeAlD
Crizotinib—LCK—Cytokine Signaling in Immune system—PTPN1—mediastinal cancer	0.000158	0.00192	CbGpPWpGaD
Crizotinib—MAP3K2—lymph node—mediastinal cancer	0.000156	0.00122	CbGeAlD
Crizotinib—CSF1R—lung—mediastinal cancer	0.000155	0.00121	CbGeAlD
Crizotinib—PTK2—lymph node—mediastinal cancer	0.000153	0.00119	CbGeAlD
Crizotinib—TBK1—lymph node—mediastinal cancer	0.000153	0.00119	CbGeAlD
Crizotinib—AXL—Signaling Pathways—PTPN1—mediastinal cancer	0.000152	0.00184	CbGpPWpGaD
Crizotinib—TYK2—lymph node—mediastinal cancer	0.000152	0.00118	CbGeAlD
Crizotinib—IRAK1—lymph node—mediastinal cancer	0.00015	0.00117	CbGeAlD
Crizotinib—ABL1—lymphoid tissue—mediastinal cancer	0.000148	0.00116	CbGeAlD
Crizotinib—RPS6KB1—lymph node—mediastinal cancer	0.000147	0.00115	CbGeAlD
Crizotinib—FGR—lymph node—mediastinal cancer	0.000146	0.00114	CbGeAlD
Crizotinib—LCK—lymph node—mediastinal cancer	0.000146	0.00114	CbGeAlD
Crizotinib—AXL—lymph node—mediastinal cancer	0.000145	0.00114	CbGeAlD
Crizotinib—SLK—lymph node—mediastinal cancer	0.00014	0.00109	CbGeAlD
Crizotinib—BMPR1B—Signaling Pathways—PTPN1—mediastinal cancer	0.000139	0.00168	CbGpPWpGaD
Crizotinib—EPHB4—lymph node—mediastinal cancer	0.000139	0.00109	CbGeAlD
Crizotinib—JAK2—lymph node—mediastinal cancer	0.000138	0.00108	CbGeAlD
Crizotinib—EPHA2—lymph node—mediastinal cancer	0.000136	0.00107	CbGeAlD
Crizotinib—TBK1—Immune System—PTPN1—mediastinal cancer	0.000136	0.00164	CbGpPWpGaD
Crizotinib—ABL1—bone marrow—mediastinal cancer	0.000135	0.00106	CbGeAlD
Crizotinib—ABL1—thyroid gland—mediastinal cancer	0.000135	0.00105	CbGeAlD
Crizotinib—MAP4K5—lymph node—mediastinal cancer	0.000133	0.00104	CbGeAlD
Crizotinib—MAP3K3—lymph node—mediastinal cancer	0.000133	0.00104	CbGeAlD
Crizotinib—TEK—lymph node—mediastinal cancer	0.000133	0.00104	CbGeAlD
Crizotinib—MAP3K3—Immune System—PTPN1—mediastinal cancer	0.00013	0.00158	CbGpPWpGaD
Crizotinib—EPHB6—lymph node—mediastinal cancer	0.000127	0.000993	CbGeAlD
Crizotinib—CYP3A5—hematopoietic system—mediastinal cancer	0.000123	0.000965	CbGeAlD
Crizotinib—JAK3—Immune System—PTPN1—mediastinal cancer	0.000123	0.00149	CbGpPWpGaD
Crizotinib—YES1—lymph node—mediastinal cancer	0.000123	0.00096	CbGeAlD
Crizotinib—ABL1—lung—mediastinal cancer	0.000122	0.000958	CbGeAlD
Crizotinib—STK10—lymph node—mediastinal cancer	0.000122	0.000951	CbGeAlD
Crizotinib—FES—Signaling Pathways—PTPN1—mediastinal cancer	0.000121	0.00147	CbGpPWpGaD
Crizotinib—TAOK3—lymph node—mediastinal cancer	0.000121	0.000947	CbGeAlD
Crizotinib—LYN—Hemostasis—PTPN1—mediastinal cancer	0.00012	0.00146	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—PTPN1—mediastinal cancer	0.00012	0.00145	CbGpPWpGaD
Crizotinib—SRC—lymph node—mediastinal cancer	0.000118	0.000923	CbGeAlD
Crizotinib—JAK2—Hemostasis—PTPN1—mediastinal cancer	0.000113	0.00136	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—PTPN1—mediastinal cancer	0.00011	0.00133	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—PTPN1—mediastinal cancer	0.000109	0.00132	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—PTPN1—mediastinal cancer	0.000108	0.00131	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—PTPN1—mediastinal cancer	0.000107	0.0013	CbGpPWpGaD
Crizotinib—CSF1R—lymph node—mediastinal cancer	0.000106	0.000829	CbGeAlD
Crizotinib—BLK—Immune System—PTPN1—mediastinal cancer	0.000105	0.00127	CbGpPWpGaD
Crizotinib—FGR—Immune System—PTPN1—mediastinal cancer	0.000105	0.00127	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—PTPN1—mediastinal cancer	9.87e-05	0.00119	CbGpPWpGaD
Crizotinib—CYP3A4—hematopoietic system—mediastinal cancer	9.26e-05	0.000724	CbGeAlD
Crizotinib—SRC—Hemostasis—PTPN1—mediastinal cancer	8.74e-05	0.00106	CbGpPWpGaD
Crizotinib—PTK2—Immune System—PTPN1—mediastinal cancer	8.59e-05	0.00104	CbGpPWpGaD
Crizotinib—YES1—Immune System—PTPN1—mediastinal cancer	8.47e-05	0.00102	CbGpPWpGaD
Crizotinib—ABL1—lymph node—mediastinal cancer	8.38e-05	0.000655	CbGeAlD
Crizotinib—IRAK1—Immune System—PTPN1—mediastinal cancer	8.03e-05	0.000972	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—PTPN1—mediastinal cancer	7.94e-05	0.000961	CbGpPWpGaD
Crizotinib—TYK2—Immune System—PTPN1—mediastinal cancer	7.8e-05	0.000944	CbGpPWpGaD
Crizotinib—CYP3A5—lung—mediastinal cancer	7.17e-05	0.000561	CbGeAlD
Crizotinib—RIPK2—Signaling Pathways—PTPN1—mediastinal cancer	7.08e-05	0.000856	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—PTPN1—mediastinal cancer	6.97e-05	0.000844	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—PTPN1—mediastinal cancer	6.67e-05	0.000808	CbGpPWpGaD
Crizotinib—ABCB1—hematopoietic system—mediastinal cancer	6.56e-05	0.000513	CbGeAlD
Crizotinib—RPS6KB1—Signaling Pathways—PTPN1—mediastinal cancer	6.47e-05	0.000783	CbGpPWpGaD
Crizotinib—LYN—Immune System—PTPN1—mediastinal cancer	6.31e-05	0.000764	CbGpPWpGaD
Crizotinib—ABL1—Immune System—PTPN1—mediastinal cancer	6.29e-05	0.000761	CbGpPWpGaD
Crizotinib—JAK2—Immune System—PTPN1—mediastinal cancer	5.91e-05	0.000715	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—PTPN1—mediastinal cancer	5.55e-05	0.000672	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—PTPN1—mediastinal cancer	5.48e-05	0.000663	CbGpPWpGaD
Crizotinib—ABCB1—trachea—mediastinal cancer	5.3e-05	0.000415	CbGeAlD
Crizotinib—IRAK1—Signaling Pathways—PTPN1—mediastinal cancer	5.19e-05	0.000629	CbGpPWpGaD
Crizotinib—LCK—Immune System—PTPN1—mediastinal cancer	5.18e-05	0.000626	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—PTPN1—mediastinal cancer	5.04e-05	0.00061	CbGpPWpGaD
Crizotinib—ABCB1—lymphoid tissue—mediastinal cancer	4.62e-05	0.000361	CbGeAlD
Crizotinib—SRC—Immune System—PTPN1—mediastinal cancer	4.58e-05	0.000555	CbGpPWpGaD
Crizotinib—ABCB1—bone marrow—mediastinal cancer	4.2e-05	0.000329	CbGeAlD
Crizotinib—ABCB1—thyroid gland—mediastinal cancer	4.19e-05	0.000328	CbGeAlD
Crizotinib—LYN—Signaling Pathways—PTPN1—mediastinal cancer	4.08e-05	0.000494	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—PTPN1—mediastinal cancer	3.82e-05	0.000462	CbGpPWpGaD
Crizotinib—ABCB1—lung—mediastinal cancer	3.81e-05	0.000298	CbGeAlD
Crizotinib—LCK—Signaling Pathways—PTPN1—mediastinal cancer	3.35e-05	0.000405	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PTPN1—mediastinal cancer	2.96e-05	0.000359	CbGpPWpGaD
Crizotinib—ABCB1—lymph node—mediastinal cancer	2.6e-05	0.000204	CbGeAlD
